115 related articles for article (PubMed ID: 32787363)
1. Preliminary exploration on the role of clinical pharmacists in cancer pain pharmacotherapy.
Su YJ; Yan YD; Wang WJ; Xu T; Gu ZC; Bai YR; Lin HW
Ann Palliat Med; 2020 Sep; 9(5):3070-3077. PubMed ID: 32787363
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of pharmacists' interventions on drug-related problems and drug costs in patients with cancer pain.
Zhang P; Lv D; Zhao J; Sun S; Li L; Liao Y
Int J Clin Pharm; 2021 Oct; 43(5):1274-1282. PubMed ID: 33625653
[TBL] [Abstract][Full Text] [Related]
3. Identification of drug-related problems followed by clinical pharmacist interventions in an outpatient pharmacotherapy clinic.
Shahrami B; Sefidani Forough A; Najmeddin F; Hadidi E; Toomaj S; Javadi MR; Gholami K; Sadeghi K
J Clin Pharm Ther; 2022 Jul; 47(7):964-972. PubMed ID: 35218217
[TBL] [Abstract][Full Text] [Related]
4. Drug-related problems among hospitalized cancer pain patients: an investigative single-arm intervention trial.
Su YJ; Yan YD; Wang WJ; Xu T; Gu ZC; Bai YR; Lin HW
Ann Palliat Med; 2021 Feb; 10(2):2008-2017. PubMed ID: 33353357
[TBL] [Abstract][Full Text] [Related]
5. Characteristic of drug-related problems and pharmacists' interventions in a stroke unit in Thailand.
Semcharoen K; Supornpun S; Nathisuwan S; Kongwatcharapong J
Int J Clin Pharm; 2019 Aug; 41(4):880-887. PubMed ID: 31054061
[TBL] [Abstract][Full Text] [Related]
6. Management of pharmacotherapy-related problems in acute coronary syndrome: Role of clinical pharmacist in cardiac rehabilitation unit.
Casper EA; El Wakeel LM; Saleh MA; El-Hamamsy MH
Basic Clin Pharmacol Toxicol; 2019 Jul; 125(1):44-53. PubMed ID: 30739389
[TBL] [Abstract][Full Text] [Related]
7. Pharmacists' performance of clinical interventions during adherence support medication reviews.
Hatah E; Tordoff J; Duffull SB; Braund R
Res Social Adm Pharm; 2014; 10(1):185-94. PubMed ID: 23688540
[TBL] [Abstract][Full Text] [Related]
8. Effects of a physician- and pharmacist-managed clinic on pain management in cancer patients in China.
Liu K; Huang H; Zhang L; Huang Y; Sun S; Chen X; Chen Y; Liu W; Xiao J
Basic Clin Pharmacol Toxicol; 2021 Jul; 129(1):36-43. PubMed ID: 33763950
[TBL] [Abstract][Full Text] [Related]
9. Process- and patient-reported outcomes of a multifaceted medication adherence intervention for hypertensive patients in secondary care.
Hedegaard U; Hallas J; Ravn-Nielsen LV; Kjeldsen LJ
Res Social Adm Pharm; 2016; 12(2):302-18. PubMed ID: 26088274
[TBL] [Abstract][Full Text] [Related]
10. Impacts of Pharmacists-Managed Oncology Outpatient Clinic on Resolving Drug-Related Problems in Ambulatory Neoplasm Patients: A Prospective Study in China.
Zhao X; Xu R; Wang Y; Zhu W; Hu H; Shen Z; Guo C; Zhang J
Inquiry; 2021; 58():469580211009662. PubMed ID: 33847148
[TBL] [Abstract][Full Text] [Related]
11. Pharmacist's Impact on Medication Adherence and Drug-Related Problems in Patients with Epilepsy.
Özdağ E; Fırat O; Çoban Taşkın A; Uludağ İF; Şener U; Demirkan K
Turk J Pharm Sci; 2024 Jan; 20(6):361-367. PubMed ID: 38254332
[TBL] [Abstract][Full Text] [Related]
12. Development of a Predictive Model for Drug-Related Problems in Kidney Transplant Recipients.
Covert KL; Mardis CR; Fleming JN; Pilch NA; Meadows HB; Mardis BA; Mohan P; Posadas-Salas M; Srinivas T; Taber DJ
Pharmacotherapy; 2017 Feb; 37(2):159-169. PubMed ID: 27997676
[TBL] [Abstract][Full Text] [Related]
13. Effect of Physician-Pharmacist Participation in the Management of Ambulatory Cancer Pain Through a Digital Health Platform: Randomized Controlled Trial.
Zhang L; McLeod HL; Liu KK; Liu WH; Huang HX; Huang YM; Sun SS; Chen XP; Chen Y; Liu FZ; Xiao J
JMIR Mhealth Uhealth; 2021 Aug; 9(8):e24555. PubMed ID: 34398796
[TBL] [Abstract][Full Text] [Related]
14. Impact of pharmacist-led medication management in care transitions.
Yang S
BMC Health Serv Res; 2017 Nov; 17(1):722. PubMed ID: 29132369
[TBL] [Abstract][Full Text] [Related]
15. Supporting respiratory patients in primary care: a qualitative insight from independent community pharmacists in London.
Hesso I; Kayyali R; Nabhani-Gebara S
BMC Health Serv Res; 2019 Jan; 19(1):5. PubMed ID: 30611264
[TBL] [Abstract][Full Text] [Related]
16. Clinical pharmacist interventions in managing drug-related problems in hospitalized patients with neurological diseases.
Ali MAS; Khedr EMH; Ahmed FAH; Mohamed NNE
Int J Clin Pharm; 2018 Oct; 40(5):1257-1264. PubMed ID: 29922968
[TBL] [Abstract][Full Text] [Related]
17. A multicenter quality improvement initiative on the impact of pharmacists' postdischarge follow-up to reduce medication-related acute care episodes.
Noh L; Heimerl K; Shane R
Am J Health Syst Pharm; 2020 Jun; 77(12):938-942. PubMed ID: 31960043
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of a collaborative care approach between general practitioners and clinical pharmacists in primary care community settings in elderly patients on polypharmacy in Slovenia: a cohort retrospective study reveals positive evidence for implementation.
Stuhec M; Gorenc K; Zelko E
BMC Health Serv Res; 2019 Feb; 19(1):118. PubMed ID: 30760276
[TBL] [Abstract][Full Text] [Related]
19. Effect of Continuous Pharmacist Interventions on Pain Control and Side Effect Management in Outpatients with Cancer Receiving Opioid Treatments.
Yamada M; Matsumura C; Jimaru Y; Ueno R; Takahashi K; Yano Y
Biol Pharm Bull; 2018; 41(6):858-863. PubMed ID: 29863074
[TBL] [Abstract][Full Text] [Related]
20. Optimizing the pharmacotherapy of vascular surgery patients by medication reconciliation.
Hohn N; Langer S; Kalder J; Jacobs MJ; Marx G; Eisert A
J Cardiovasc Surg (Torino); 2014 Apr; 55(2 Suppl 1):175-81. PubMed ID: 24796911
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
